Please login to the form below

Not currently logged in
Email:
Password:

launch

This page shows the latest launch news and features for those working in and with pharma, biotech and healthcare.

Novartis’ heart failure drug Entresto proves superior to enalapril

Novartis’ heart failure drug Entresto proves superior to enalapril

However, Entresto has underperformed against expectations since its launch in 2015.

Latest news

More from news
Approximately 10 fully matching, plus 1,522 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    One potential major product launch for 2019 will be novel pain drug tanezumab.

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Alnylam and its extraordinary ‘gene silencing’technology is making its debut in Europe with the launch of Onpattro. ... PME talks to its European leader Theresa Heggie. Even as it launches its first ever product Onpattro, Alnylam is already a biotech

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    That was down to an impressive set-up, launches and regulatory milestones over the previous 12 months. ... Two of these five new launches received accelerated approval, confirming their innovative status, plus the firm also clocked up 14 other regulatory

  • KAM 2.0 KAM 2.0

    We recently worked on a programme with a global top 15 pharmaceutical company with a vast product portfolio and an imminent, crucial product launch. ... With the relationship and goodwill established, and clear tangible outcomes after the initial meeting,

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    Other key launches will include Lynparza, its ovarian cancer treatment, now co-marketed globally with MSD. ... To conclude, there is no doubt that the US, Europe and Japan remain the lead launch markets.

More from intelligence
Approximately 0 fully matching, plus 217 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 131 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 17 fully matching, plus 361 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics